Specialties

Otolaryngology - Head and Neck Surgery.

Clinical Interests

Laryngology and head and neck surgery, especially the comprehensive treatment for Snoring/Obstructive sleep apnea hypopnea syndrome(OSAHS) and Head and Neck Tumors.

Experience

Nov. 2019-present, Chief physician of Otolaryngology - Head and Neck Surgery Guangdong Provincial People’s Hospital, Guangzhou, China

May. 2016 -May. 2017, Visiting Scholar

Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, TX, US

Education

Jun. 2018, Doctor’s degree

Otolaryngology, Southern Medical University, Guangzhou, China. Supervisor: Prof. Xiangping Li

Awards and Honors

2019, Guangdong Provincial Outstanding Young Medical Talent by Health Commission of Guangdong Province, Guangzhou

Professional memberships

Member, Otolaryngology Branch of Guangdong medical Doctor Association

Member, International Surgical Sleep Society

Publications

A total of 9 articles were published (as the first author or corresponding author) in SCI journals.

1. Characteristics of pharyngeal paraesthesia symptoms in patients with obstructive sleep apnoea. Sleep Breath. 2021 Feb 18. (IF :2.162)

2. MiR-125a-5p inhibits cell proliferation, cell cycle progression, and migration while promoting apoptosis in head and neck cancers by targeting ERBB3. Auris Nasus Larynx. 2021 Jun;48(3):477-486. Epub 2020 Oct 16.(IF :1.436)

3. A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post-operative radiotherapy. J Cell Mol Med. 2019 Oct 2. (IF: 4.302)

4. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx. Mol Carcinog. 2018 Mar;57(3):361-369. （IF :4.2）

5. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx. Int J Cancer. 2017 Oct1;141(7): 1355-1364. （IF :7.3）

6. Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx. Carcinogenesis. 2017 Apr 1; 38(4): 432-438. （IF :5.1）

7. Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma. Onco Targets Ther. 2014 Apr 5;7:525-33. (IF: 2.07)

8. Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment. PLoS One. 2013 Apr4;8(4):e60157.(IF: 3.73)

9. Supracricoid partial laryngectomy cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial laryngectomy for the treatment of glottic carcinoma. Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1027-34.(IF: 1.6)